At the close of this session, the Ibovespa ended trading at 172,451.04 points, up +0.66%. Among individual highlights, Allied (ALLD3) closed at R$ 6.99, up +17.48%, and Companhia Siderúrgica Nacional (CSNA3) ended at R$ 3.78, down -10.64%. In the previous partial reading, the index was at 172,344.08 points (+0.60%); at the open, it had marked 172,140.45 points (+0.48%).
Biggest gainers of the session:
- Allied (ALLD3): R$ 6.99 | +17.48%
- Even (EVEN3): R$ 3.61 | +11.76%
- Grupo Mateus (GMAT3): R$ 4.22 | +9.90%
- Magazine Luiza (MGLU3): R$ 7.73 | +9.34%
- Compass (PASS3): R$ 22.05 | +8.35%
Allied reported net income of R$ 33.8 million in 3Q26, with recurring income of R$ 58.6 million, up 56.7%. Even recorded net income of R$ 20 million in the quarter, down 34.2%, and net revenue of R$ 240 million, up 19.4% from 2Q26. Grupo Mateus reported income of R$ 322 million, up 33.3% from 2Q26. Magazine Luiza reported a loss of R$ 10.7 million in 3Q26 and adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) of R$ 710.1 million. Compass posted net income of R$ 591 million, up 37% from 3Q25.
Biggest losers of the session:
- CSN (CSNA3): R$ 3.78 | -10.64%
- Positivo (POSI3): R$ 3.10 | -8.01%
- Arezzo (AZZA3): R$ 16.04 | -5.09%
- Helbor Empreendimentos (HBOR3): R$ 1.16 | -4.92%
- Oncoclínicas (ONCO3): R$ 0.83 | -4.60%
CSN recorded a loss of R$ 1.2 billion in 3Q26, with a 43.5% drop in adjusted EBITDA from 3Q25 and leverage of 4.23x. The company also announced the resignation of chief financial officer Marco Rabello. Oncoclínicas postponed the release of its 3Q26 ITR (Quarterly Information), with an estimated date in the third week of December.
Also read:
